Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 7
1989 23
1990 45
1991 60
1992 92
1993 68
1994 71
1995 76
1996 72
1997 87
1998 70
1999 61
2000 77
2001 73
2002 56
2003 70
2004 52
2005 80
2006 64
2007 85
2008 89
2009 109
2010 114
2011 110
2012 112
2013 127
2014 126
2015 131
2016 117
2017 123
2018 116
2019 106
2020 141
2021 127
2022 102
2023 79
2024 34

Text availability

Article attribute

Article type

Publication date

Search Results

2,895 results

Results by year

Filters applied: . Clear all
Page 1
Drugs for Treating Obesity.
Ryan DH. Ryan DH. Handb Exp Pharmacol. 2022;274:387-414. doi: 10.1007/164_2021_560. Handb Exp Pharmacol. 2022. PMID: 34783910
Organisation of the human pancreas in health and in diabetes.
Atkinson MA, Campbell-Thompson M, Kusmartseva I, Kaestner KH. Atkinson MA, et al. Diabetologia. 2020 Oct;63(10):1966-1973. doi: 10.1007/s00125-020-05203-7. Epub 2020 Sep 7. Diabetologia. 2020. PMID: 32894306 Free PMC article. Review.
Islet amyloid polypeptide does not suppress pancreatic cancer.
Taylor AJ, Panzhinskiy E, Orban PC, Lynn FC, Schaeffer DF, Johnson JD, Kopp JL, Verchere CB. Taylor AJ, et al. Mol Metab. 2023 Feb;68:101667. doi: 10.1016/j.molmet.2023.101667. Epub 2023 Jan 5. Mol Metab. 2023. PMID: 36621763 Free PMC article.
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial.
Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, Mathieu C, Pedersen SD, Davies M. Frias JP, et al. Lancet. 2023 Aug 26;402(10403):720-730. doi: 10.1016/S0140-6736(23)01163-7. Epub 2023 Jun 23. Lancet. 2023. PMID: 37364590 Clinical Trial.
Development of Cagrilintide, a Long-Acting Amylin Analogue.
Kruse T, Hansen JL, Dahl K, Schäffer L, Sensfuss U, Poulsen C, Schlein M, Hansen AMK, Jeppesen CB, Dornonville de la Cour C, Clausen TR, Johansson E, Fulle S, Skyggebjerg RB, Raun K. Kruse T, et al. J Med Chem. 2021 Aug 12;64(15):11183-11194. doi: 10.1021/acs.jmedchem.1c00565. Epub 2021 Jul 21. J Med Chem. 2021. PMID: 34288673 Free article.
2,895 results